| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.3109/10717541003667798 |
| P8608 | Fatcat ID | release_7c2dw5syqzcntndrpcozr7s5du |
| P932 | PMC publication ID | 2906704 |
| P698 | PubMed publication ID | 20297904 |
| P5875 | ResearchGate publication ID | 42343489 |
| P50 | author | Ryan F Donnelly | Q89745523 |
| A David Woolfson | Q114401356 | ||
| Raghu Raj Thakur Singh | Q43108962 | ||
| P2860 | cites work | The mechanical properties of the skin epidermis in relation to targeted gene and drug delivery | Q80845250 |
| Microporation applications for enhancing drug delivery | Q83614631 | ||
| Coated microneedles for transdermal delivery | Q27478300 | ||
| Preclinical Evaluation of Microneedle Technology for Intradermal Delivery of Influenza Vaccines | Q27478355 | ||
| Micro-scale devices for transdermal drug delivery | Q27489779 | ||
| Polymer microneedles for controlled-release drug delivery. | Q30354515 | ||
| Transdermal delivery of insulin using microneedles in vivo | Q31080311 | ||
| Clinical microneedle injection of methyl nicotinate: stratum corneum penetration | Q33213612 | ||
| Hollow metal microneedles for insulin delivery to diabetic rats | Q33214936 | ||
| Coating formulations for microneedles | Q33279953 | ||
| Characterization of solid maltose microneedles and their use for transdermal delivery | Q33289125 | ||
| In vivo assessment of safety of microneedle arrays in human skin | Q33355420 | ||
| Microporation techniques for enhanced delivery of therapeutic agents | Q33508913 | ||
| Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies | Q33712814 | ||
| Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro | Q33975431 | ||
| Processing difficulties and instability of carbohydrate microneedle arrays. | Q33975438 | ||
| Intrascleral drug delivery to the eye using hollow microneedles | Q33978350 | ||
| Pocketed Microneedles for Drug Delivery to the Skin | Q34002511 | ||
| Microfabricated microneedles for gene and drug delivery | Q34433150 | ||
| Genome medicine promised by microarray technology | Q34569337 | ||
| Microfabricated drug delivery systems: from particles to pores | Q35082114 | ||
| Hard and soft micromachining for BioMEMS: review of techniques and examples of applications in microfluidics and drug delivery | Q35637324 | ||
| Integrated microsystems for controlled drug delivery | Q35637331 | ||
| Micromachined biocapsules for cell-based sensing and delivery | Q35637339 | ||
| Bioabsorbable implants: review of clinical experience in orthopedic surgery. | Q35667853 | ||
| Microneedles for transdermal drug delivery | Q35690686 | ||
| Minimally invasive protein delivery with rapidly dissolving polymer microneedles | Q36458988 | ||
| Dissolving microneedles for transdermal drug delivery | Q36540738 | ||
| Microneedles and transdermal applications | Q36690205 | ||
| Microneedles permit transdermal delivery of a skin-impermeant medication to humans | Q36883065 | ||
| Microstructured devices for transdermal drug delivery and minimally-invasive patient monitoring | Q37347798 | ||
| Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles | Q37426334 | ||
| Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates. | Q40468588 | ||
| Mechanics of a mosquito bite with applications to microneedle design | Q42981513 | ||
| Tapered conical polymer microneedles fabricated using an integrated lens technique for transdermal drug delivery | Q43548910 | ||
| Transdermal delivery of desmopressin using a coated microneedle array patch system | Q44948638 | ||
| Molecular charge mediated transport of a 13 kD protein across microporated skin. | Q45980619 | ||
| Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin. | Q45990071 | ||
| Skin penetration enhancement by a microneedle device (Dermaroller) in vitro: dependency on needle size and applied formulation | Q46161199 | ||
| In vitro transdermal delivery of therapeutic antibodies using maltose microneedles | Q46256512 | ||
| Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery | Q46468179 | ||
| Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system | Q46483913 | ||
| Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy | Q46538289 | ||
| Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes | Q46552161 | ||
| Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein | Q46645701 | ||
| Improved piercing of microneedle arrays in dermatomed human skin by an impact insertion method. | Q46659788 | ||
| Sugar micro needles as transdermic drug delivery system | Q46679659 | ||
| Painless drug delivery through microneedle-based transdermal patches featuring active infusion | Q46707523 | ||
| Microinfusion using hollow microneedles | Q46820785 | ||
| Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate | Q46844120 | ||
| Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults | Q47225463 | ||
| Evaluation of self-dissolving needles containing low molecular weight heparin (LMWH) in rats | Q47271319 | ||
| Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin. | Q47307495 | ||
| Clinical administration of microneedles: skin puncture, pain and sensation. | Q47426250 | ||
| Gene delivery to the epidermal cells of human skin explants using microfabricated microneedles and hydrogel formulations | Q48087507 | ||
| Novel microneedle patches for active insulin delivery are efficient in maintaining glycaemic control: an initial comparison with subcutaneous administration | Q48611030 | ||
| Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice. | Q50453540 | ||
| Feasibility of microneedles for percutaneous absorption of insulin. | Q50478176 | ||
| Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. | Q50859911 | ||
| Membrane-sealed hollow microneedles and related administration schemes for transdermal drug delivery. | Q50887659 | ||
| Coated microneedles for drug delivery to the eye. | Q50925584 | ||
| Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines. | Q50953575 | ||
| Controlled transdermal delivery of model drug compounds by MEMS microneedle array. | Q51067120 | ||
| Enhancement of skin permeation of high molecular compounds by a combination of microneedle pretreatment and iontophoresis. | Q51075549 | ||
| Mechanism of fluid infusion during microneedle insertion and retraction. | Q51222494 | ||
| Precise microinjection into skin using hollow microneedles. | Q51269769 | ||
| Microneedle insertion force reduction using vibratory actuation. | Q51613436 | ||
| Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force. | Q51658246 | ||
| Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery. | Q51832256 | ||
| Microfabricated Microneedles: A Novel Approach to Transdermal Drug Delivery | Q59885457 | ||
| Microbiologic evaluation of needleless and needle-access devices | Q64133568 | ||
| Genetic transformation of nematodes using arrays of micromechanical piercing structures | Q70970653 | ||
| Lack of pain associated with microfabricated microneedles | Q73399627 | ||
| Lab-on-a-Cable for electrochemical monitoring of phenolic contaminants | Q73904406 | ||
| Self-dissolving microneedles for the percutaneous absorption of EPO in mice | Q80043504 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microfabrication | Q175538 |
| drug delivery | Q1392806 | ||
| P304 | page(s) | 187-207 | |
| P577 | publication date | 2010-05-01 | |
| P1433 | published in | Drug Delivery | Q5308838 |
| P1476 | title | Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety | |
| P478 | volume | 17 |
| Q58576353 | 3D Printing, Ink Casting and Micromachined Lamination (3D PICLμM): A Makerspace Approach to the Fabrication of Biological Microdevices |
| Q33455123 | A minimally invasive microchip for transdermal injection/sampling applications |
| Q36181678 | A novel scalable manufacturing process for the production of hydrogel-forming microneedle arrays |
| Q38850080 | A pilot comparative study of topical latanoprost and tacrolimus in combination with narrow-band ultraviolet B phototherapy and microneedling for the treatment of nonsegmental vitiligo |
| Q33641450 | A review of laser and light therapy in melasma |
| Q64951790 | Acid-Treated Water-Soluble Chitosan Suitable for Microneedle-Assisted Intracutaneous Drug Delivery. |
| Q37792508 | Advances in transcutaneous vaccine delivery: Do all ways lead to Rome? |
| Q47764934 | An acryl resin-based swellable microneedles for controlled release intradermal delivery of granisetron |
| Q40870405 | Assessment of the efficacy of drug transdermal delivery by electro-phonophoresis in treating tuberculous lymphadenitis |
| Q35079453 | Bacillus Calmette-Guérin vaccination using a microneedle patch. |
| Q38860500 | Considerations in the use of microneedles: pain, convenience, anxiety and safety |
| Q28658143 | Continuous drug release by sea anemone Nematostella vectensis stinging microcapsules |
| Q43587961 | Continuous minimally-invasive alcohol monitoring using microneedle sensor arrays |
| Q90672905 | Continuous organic synthesis in water around micro-orifices after flows |
| Q37468550 | Controlled Drug Delivery Using Microdevices |
| Q47778162 | Cutaneous vaccination with coated microneedles prevents development of airway allergy |
| Q35740055 | Delivery of salmon calcitonin using a microneedle patch |
| Q36762321 | Development of vertical SU-8 microtubes integrated with dissolvable tips for transdermal drug delivery |
| Q93234296 | Differences in biocompatibility of microneedles from cyclic olefin polymers with human endothelial and epithelial skin cells |
| Q37503108 | Dissolvable microneedle arrays for intradermal delivery of biologics: fabrication and application |
| Q28391616 | Effect of microneedle treatment on the skin permeation of a nanoencapsulated dye |
| Q34663269 | Effect of photodynamic therapy on the skin using the ultrashort laser ablation |
| Q41774997 | Effects of chemical and physical enhancement techniques on transdermal delivery of cyanocobalamin (vitamin B12) in vitro |
| Q50442634 | Effects of microneedle length, density, insertion time and multiple applications on human skin barrier function: Assessments by transepidermal water loss |
| Q37424166 | Evaluation of a minimally invasive glucose biosensor for continuous tissue monitoring |
| Q46268392 | Faster pharmacokinetics and increased patient acceptance of intradermal insulin delivery using a single hollow microneedle in children and adolescents with type 1 diabetes |
| Q28554858 | Flexible and Stretchable Microneedle Patches with Integrated Rigid Stainless Steel Microneedles for Transdermal Biointerfacing |
| Q41501957 | H2O2-Responsive Vesicles Integrated with Transcutaneous Patches for Glucose-Mediated Insulin Delivery |
| Q47410320 | Immunotherapeutic effect of BCG-polysaccharide nucleic acid powder on Mycobacterium tuberculosis-infected mice using microneedle patches |
| Q26829514 | In vitro and in vivo models for the study of oral delivery of nanoparticles |
| Q57095879 | In-vitro perforation of the round window membrane via direct 3-D printed microneedles |
| Q89287740 | Individually coated microneedles for co-delivery of multiple compounds with different properties |
| Q30462818 | Infusion pressure and pain during microneedle injection into skin of human subjects |
| Q35929406 | Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear |
| Q34511156 | Intrastromal delivery of bevacizumab using microneedles to treat corneal neovascularization |
| Q35830407 | Investigation of Plasma Treatment on Micro-Injection Moulded Microneedle for Drug Delivery |
| Q35187866 | Kinetics of skin resealing after insertion of microneedles in human subjects |
| Q33994211 | Laser-engineered dissolving microneedles for active transdermal delivery of nadroparin calcium |
| Q34553383 | Layer-by-layer assembly of DNA- and protein-containing films on microneedles for drug delivery to the skin |
| Q37989486 | Lentiviral vectors for cutaneous RNA managing |
| Q50890208 | Long-term stability of influenza vaccine in a dissolving microneedle patch. |
| Q38105616 | Microarrays and microneedle arrays for delivery of peptides, proteins, vaccines and other applications |
| Q36501907 | Microfabrication technologies for oral drug delivery |
| Q96130508 | Microneedle Mediated Transdermal Delivery of Protein, Peptide and Antibody Based Therapeutics: Current Status and Future Considerations |
| Q30418015 | Microneedle and mucosal delivery of influenza vaccines |
| Q38417547 | Microneedle applications in improving skin appearance. |
| Q38770048 | Microneedle arrays delivery of the conventional vaccines based on nonvirulent viruses |
| Q38506865 | Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation. |
| Q36077060 | Microneedle delivery of plasmid DNA to living human skin: Formulation coating, skin insertion and gene expression |
| Q89861710 | Microneedle-Facilitated Intradermal Proretinal Nanoparticle Delivery |
| Q47952817 | Microneedle-assisted permeation of lidocaine carboxymethylcellulose with gelatine co-polymer hydrogel |
| Q90254723 | Microneedle-based device for the one-step painless collection of capillary blood samples |
| Q37187438 | Microneedle-mediated transdermal bacteriophage delivery |
| Q37999873 | Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy |
| Q26746026 | Microneedles As a Delivery System for Gene Therapy |
| Q36164749 | Microneedles for drug and vaccine delivery |
| Q63431938 | Minimally Invasive and Regenerative Therapeutics |
| Q35084780 | Nanostructured lipid carrier-loaded hyaluronic acid microneedles for controlled dermal delivery of a lipophilic molecule |
| Q53075107 | Nonenzymatic determination of glucose at near neutral pH values based on the use of nafion and platinum black coated microneedle electrode array. |
| Q38122744 | Novel engineered systems for oral, mucosal and transdermal drug delivery. |
| Q38318837 | Ocular drug delivery systems: An overview |
| Q36912005 | Optically monitored drug delivery patch based on porous silicon and polymer microneedles |
| Q54959860 | Peptide delivery with poly(ethylene glycol) diacrylate microneedles through swelling effect. |
| Q35090493 | Permeation of antigen protein-conjugated nanoparticles and live bacteria through microneedle-treated mouse skin |
| Q38610750 | Physical Delivery of Macromolecules using High-Aspect Ratio Nanostructured Materials. |
| Q30370201 | Physical non-viral gene delivery methods for tissue engineering |
| Q50169459 | Polymeric microneedles for transdermal protein delivery |
| Q38108243 | Potential of biodegradable microneedles as a transdermal delivery vehicle for lidocaine |
| Q38169249 | Potential of microneedle-assisted micro-particle delivery by gene guns: a review |
| Q37396059 | Rapidly dissolving polymeric microneedles for minimally invasive intraocular drug delivery |
| Q47666014 | Recent advances of controlled drug delivery using microfluidic platforms. |
| Q38501328 | Recent insights into cutaneous immunization: How to vaccinate via the skin |
| Q64881146 | Self-healing encapsulation and controlled release of vaccine antigens from PLGA microparticles delivered by microneedle patches. |
| Q28553947 | Single-Step Fabrication of Computationally Designed Microneedles by Continuous Liquid Interface Production |
| Q53258287 | Small is beautiful: N-trimethyl chitosan-ovalbumin conjugates for microneedle-based transcutaneous immunisation. |
| Q38104408 | Strategies for enhanced peptide and protein delivery |
| Q94538986 | Stress and Deformation of Optimally Shaped Silicon Microneedles for Transdermal Drug Delivery |
| Q53627858 | Structural characterization and in-vivo reliability evaluation of silicon microneedles. |
| Q42799142 | Targeting dendritic cells with antigen via dendritic cell-associated promoters. |
| Q90398951 | Technology update: dissolvable microneedle patches for vaccine delivery |
| Q38799509 | The success of microneedle-mediated vaccine delivery into skin. |
| Q92417128 | Transcutaneous immunization of recombinant Staphylococcal enterotoxin B protein using a dissolving microneedle provides potent protection against lethal enterotoxin challenge |
| Q38073800 | Transcutaneous vaccines--current and emerging strategies |
| Q92369536 | Transdermal Delivery of Sumatriptan Succinate Using Iontophoresis and Dissolving Microneedles |
| Q26778469 | Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum |
| Q28481022 | Transdermal delivery of scopolamine by natural submicron injectors: in-vivo study in pig |
| Q99570894 | Vaccination into the Dermal Compartment: Techniques, Challenges, and Prospects |
Search more.